Table 1.
Correlation between expression of TSG-6 and clinicopathological features in CRC patients
| Variables | Low TSG-6 (n=120) | High TSG-6 (n=86) | P value |
|---|---|---|---|
| Gender | 0.001** | ||
| Male | 80(66.7%) | 37(43.0%) | |
| Female | 40(33.3%) | 49(57.0%) | |
| Median age | 0.85 | ||
| ≤67 years | 63(52.5%) | 44(51.2%) | |
| >67 years | 57(47.5%) | 42(48.8%) | |
| pT stage | 0.057 | ||
| T1 | 8(6.7%) | 7(8.1%) | |
| T2 | 29(24.2%) | 18(20.9%) | |
| T3 | 76(63.3%) | 46(53.5%) | |
| T4 | 7(5.8%) | 15(17.4%) | |
| pN stage | <0.0001*** | ||
| N0 | 98(81.7%) | 46(53.5%) | |
| N1 | 19(15.8%) | 31(36.0%) | |
| N2 | 3(2.5%) | 9(10.5%) | |
| pM stage | 0.002** | ||
| M0 | 112(93.3%) | 68(79.1%) | |
| M1 | 8(6.7%) | 18(20.9%) | |
| TNM stage | <0.0001*** | ||
| I | 36(30.0%) | 24(27.9%) | |
| II | 59(49.2%) | 20(23.3%) | |
| III | 17(14.2%) | 24(27.9%) | |
| IV | 8(6.6%) | 18(20.9%) | |
| Histological grade | 0.069 | ||
| G1 | 45(37.5%) | 27(31.4%) | |
| G2 | 73(60.8%) | 52(60.5%) | |
| G3 | 2(1.7%) | 7(8.1%) |
All data are shown as numbers and percentages. TSG-6 Low is defined as IHC score≤4 and TSG-6 High is defined as IHC score>4. *p<0.05, **p<0.01, ***p<0.001.